Pathological complete response with nivolumab for recurrence of liver metastasis after gastrectomy of gastric cancer

Ito S, Oki E, Nakashima Y, Ando K, Hiyoshi Y, Ohgaki K, Saeki H, Morita M, Sakaguchi Y, Maehara Y. Clinical significance of adjuvant surgery following chemotherapy for patients with initially unresectable stage IV gastric cancer. Anticancer Res. 2015;35:401–6.

PubMed  Google Scholar 

Kanda T, Yajima K, Kosugi S, Ishikawa T, Ajioka Y, Hatakeyama K. Gastrectomy as a secondary surgery for stage IV gastric cancer patients who underwent S-1-based chemotherapy: a multi-institute retrospective study. Gastric Cancer. 2012;15:235–44.

Article  PubMed  Google Scholar 

Chen LT, Satoh T, Ryu MH, Chao Y, Kato K, Chung HC, Chen JS, Muro K, Kang WK, Yeh KH, Yoshikawa T, Oh SC, Bai LY, Tamura T, Lee KW, Hamamoto Y, Kim JG, Chin K, Oh DY, Minashi K, Cho JY, Tsuda M, Sameshima H, Kang YK, Boku N. A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data. Gastric Cancer. 2020;23:510–9.

Article  CAS  PubMed  Google Scholar 

JGC Association. Japanese classification of gastric carcinoma: 3rd english edition. Gastric Cancer. 2011;14:101–12.

Article  Google Scholar 

Bearz A, Perin T, Cancian L, Berto E, Sartor I, Tirelli U. Immune checkpoint inhibitors and response analysis: a tough challenge. A case report. BMC Res Notes. 2016;9:349.

Article  PubMed  PubMed Central  Google Scholar 

Kinoshita T, Kinoshita T, Saiura A, Esaki M, Sakamoto H, Yamanaka T. Multicentre analysis of long-term outcome after surgical resection for gastric cancer liver metastases. Br J Surg. 2015;102:102–7.

Article  CAS  PubMed  Google Scholar 

Oki E, Tokunaga S, Emi Y, Kusumoto T, Yamamoto M, Fukuzawa K, Takahashi I, Ishigami S, Tsuji A, Higashi H, Nakamura T, Saeki H, Shirabe K, Kakeji Y, Sakai K, Baba H, Nishimaki T, Natsugoe S, Maehara Y. Surgical treatment of liver metastasis of gastric cancer: a retrospective multicenter cohort study (KSCC1302). Gastric Cancer. 2016;19:968–76.

Article  PubMed  Google Scholar 

Yoshida K, Yamaguchi K, Okumura N, Tanahashi T, Kodera Y. Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification. Gastric Cancer. 2016;19:329–38.

Article  PubMed  Google Scholar 

Matsumoto R, Arigami T, Matsushita D, Okubo K, Tanaka T, Yanagita S, Sasaki K, Noda M, Kita Y, Mori S, Kurahara H, Ohtsuka T. Conversion surgery for stage IV gastric cancer with a complete pathological response to nivolumab: a case report. World J Surg Oncol. 2020;18:179.

Article  PubMed  PubMed Central  Google Scholar 

Japanese gastric cancer treatment guidelines. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. 2018;24:1–21.

Article  Google Scholar 

Hirata K, Tamaki N. Quantitative FDG PET assessment for oncology therapy. Cancers (Basel). 2021;13:869.

Article  CAS  PubMed  Google Scholar 

Vitolo U, Trněný M, Belada D, Burke JM, Carella AM, Chua N, Abrisqueta P, Demeter J, Flinn I, Hong X, Kim WS, Pinto A, Shi YK, Tatsumi Y, Oestergaard MZ, Wenger M, Fingerle-Rowson G, Catalani O, Nielsen T, Martelli M, Sehn LH. Obinutuzumab or rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated diffuse large B-cell lymphoma. J Clin Oncol. 2017;35:3529–37.

Article  CAS  PubMed  Google Scholar 

Dai P, Rao X, Zhang X, Qiu E, Wu G, Lin Y, Li S, Li Z, Cai Z, Han S. Case report: complete remission of a patient with metastatic gastric cancer treated with nivolumab combined with chemotherapy after palliative surgery. Front Immunol. 2022;13: 908558.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Toyota K, Hashimoto Y, Sakashita Y, Yokoyama Y, Murakami Y, Takahashi S, Miyamoto K. Pathological complete response to Nivolumab, S1, Oxaliplatin, and radiation in a patient with gastric cancer: a case report. J Gastrointest Cancer. 2022. https://doi.org/10.1007/s12029-022-00895-z.

Article  PubMed  Google Scholar 

Pan Y, Lu L, Liu H, Chen D, Han N, Yao R, Wang X, Gao X, Yu J, Chen L, Zhou F, Hao G, Lu Y, Li M, He G, Kang F, Li Z, Tang Y, Zhang J, Wei L, Nie Y. Case report: Long response to PD-1 blockade after failure of trastuzumab plus chemotherapy in advanced Epstein-Barr virus-associated gastric cancer. Front Immunol. 2022;13:1003859.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Takami T, Yasuda K, Uozumi N, Musiake Y, Shintani H, Kataoka N, Yamaguchi T, Makimoto S. Confirmed complete response to nivolumab for advanced gastric cancer with peritoneal dissemination: a case report. J Med Case Rep. 2021;15:604.

Article  PubMed  PubMed Central  Google Scholar 

Watanabe H, Fujikawa H, Komori K, Kano K, Takahashi K, Yamada T, Inokuchi Y, Machida N, Yokose T, Rino Y, Masuda M, Ogata T, Oshima T. Successful conversion surgery for stage IV gastric cancer after nivolumab monotherapy as third-line chemotherapy. Case Rep Gastroenterol. 2021;15:562–7.

Article  PubMed  PubMed Central  Google Scholar 

Kumamoto T, Tomita T, Hojo Y, Nakamura T, Kurahashi Y, Ishida Y, Miwa H, Hirota S, Shinohara H. Pathological complete response and successful conversion surgery after nivolumab therapy for stage IV oesophagogastric junction cancer. In Vivo. 2021;35:2247–51.

Article  PubMed  PubMed Central  Google Scholar 

Komo T, Suzuki T, Tazawa H, Sada H, Morimoto H, Shimada N, Hadano N, Onoe T, Sudo T, Shimizu Y, Tashiro H. Clinical complete response after nivolumab administered as a third-line treatment for unresectable advanced gastric cancer with peritoneal dissemination: a case report. Int J Surg Case Rep. 2021;84: 106161.

Article  PubMed  PubMed Central  Google Scholar 

Kuhara Y, Ninomiya M, Hirahara S, Doi H, Kenji S, Toyota K, Yano R, Kobayashi H, Hashimoto Y, Yokoyama Y, Sakashita Y, Miyamoto K. A long-term survival case of unresectable gastric cancer with multidisciplinary therapy including immunotherapy and abscopal effect. Int Cancer Conf J. 2020;9:193–8.

Article  PubMed  PubMed Central  Google Scholar 

Toyota S, Orita H, Fukuyama Y, Motoyoshi S, Kawanami S, Maeda S, Kuramitsu E, Ichimanda M, Nagamatsu S, Nagata S, Kai S, Korenaga D, Mori M. Successful conversion surgery following chylous ascites after nivolumab for advanced gastric cancer. In Vivo. 2020;34:583–5.

Article  PubMed  PubMed Central  Google Scholar 

Toyota S, Naito H, Motoyoshi S, Nakanishi R, Oki E, Orita H, Korenaga D. Extended total gastrectomy after nivolumab for unresectable multivisceral invasive gastric cancer. Surg Case Rep. 2020;6:298.

Article  PubMed  PubMed Central  Google Scholar 

Kashima S, Tanabe H, Tanino M, Kobayashi Y, Murakami Y, Iwama T, Sasaki T, Kunogi T, Takahashi K, Ando K, Ueno N, Moriichi K, Fukudo M, Tasaki Y, Hosokawa M, Mizukami Y, Fujiya M, Okumura T. Lymph node metastasis from gastroesophageal cancer successfully treated by nivolumab: a case report of a young patient. Front Oncol. 2019;9:1375.

Article  PubMed  PubMed Central  Google Scholar 

Namikawa T, Ishida N, Tsuda S, Fujisawa K, Munekage E, Iwabu J, Munekage M, Uemura S, Tsujii S, Maeda H, Kitagawa H, Kobayashi M, Hanazaki K. Successful treatment of liver metastases arising from early gastric cancer achieved clinical complete response by nivolumab. Surg Case Rep. 2018;4:71.

Article  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif